Expert Interview
A look at the FDA's approval for an obesity management drug for those with ultra-rare genetic diseases, this time for Bardet-Biedl syndrome
Ticker(s): RYTMInstitution: University of Kansas
- Director, Division of Research and Genetics, Director, KUMC Genetics Clinic & ABMG Certified Clinical Geneticist and Clinical Cytogeneticist.
- Research interests include the genetics of obesity with emphasis on Prader-Willi syndrome and obesity-related disorders, autism, psychiatric and behavioral genetics, genotype-phenotype correlations and the natural history and delineation of rare and uncommon clinical genetics syndromes.
- Has published over 400 research articles, multiple book chapters and edited several journal issues and two textbooks.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
